Iceland· IS-EU/1/22/1700/001
Ebvallo
A tabelecleucel product containing tabelecleucel, registered in Iceland by Pierre Fabre Medicament. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Tabelecleucel is registered in 11 of 19 countries.
Countries holding a registration under ATC L01XL09 (tabelecleucel), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Tabelecleucel · ATC L01XL09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Tabelecleucel
- Manufacturer
- Pierre Fabre Medicament
- Country
- Iceland (IS)
- ATC code
- L01XL09
- ATC class
- Tabelecleucel
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tabelecleucel in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEbvallo 2.8 10*7 cells/ml - 7.3 10*7 cells/mlPierre Fabre Médicament
- SwitzerlandEbvallo, InjektionsdispersionPierre Fabre Pharma SA
- CzechiaEBVALLOPIERRE FABRE MEDICAMENT, Lavaur
- SpainEBVALLO 2,8 × 10E7 - 7,3 × 10E7 CÉLULAS /ML DISPERSION INYECTABLEPierre Fabre Medicament
- FinlandEbvalloPierre Fabre Medicament
- FranceEBVALLO 2,8 x 10 000 000 - 7,3 x 10 000 000 cellules/mL, dispersion injectablePIERRE FABRE MEDICAMENT
- IrelandEbvallo 2.8 × 10^7 – 7.3 × 10^7 cells/mL dispersion for injectionPierre Fabre Medicament
- NetherlandsEbvallo 5×10E7 cellen/ml, dispersie voor injectiePierre Fabre Medicament
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Ebvallo
- Norway · Ebvallo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b27e456-47cf-47a1-b6c9-dd7cab7a0a70 GET /v1/drugs/2b27e456-47cf-47a1-b6c9-dd7cab7a0a70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, ördreifa",
"source": "lyfjastofnun",
"atc_raw": "L01XL09",
"marketed": false,
"strength": "2,8 x 10e7-7,3 x 10e7 frumur/ml",
"ma_number": "EU/1/22/1700/001",
"substance": "Tabelecleucel",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44911"
}See everything about tabelecleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.